Brief: Intelgenx Technologies - Anticipates Entering Into One Or More Commercial Partnership Agreements For Vetafilm Technology Before End Of 2023
31/05/2023 13:15
May 31 (Reuters) - Intelgenx Technologies Corp IGX.TO :
* INTELGENX TECHNOLOGIES - ANTICIPATES ENTERING INTO ONE OR
MORE
COMMERCIAL PARTNERSHIP AGREEMENTS FOR VETAFILM TECHNOLOGY BEFORE
END OF 2023
* INTELGENX - GENSCO PHARMA, CO'S COMMERCIAL PARTNER FOR
RIZAFILM
IN U.S., TARGETING MANUFACTURING OF VALIDATION BATCHES FOR LATER
IN 2023
* INTELGENX TECHNOLOGIES - CONTINUING TO WORK WITH EXELTIS
HEALTHCARE S.L., COMMERCIALIZATION PARTNER IN EU FOR RIZAPORT,
TO EXPAND SALES IN SPAIN
Source text for Eikon: ID:nGNX8Gk2Bb
Further company coverage: IGX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA